Skip to content

Clinical trials

Completed Scleroderma, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Completed Country / region: United States Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20041
20054
20062
20076
20086
20094
20104
20115
20122
20133
20141
20156
20165
20173
20183
20193
20202
20211
20221
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan9
Fred Hutchinson Cancer Center4
Stanford University4
Hospital for Special Surgery, New York3
Johns Hopkins University3
National Institute of Allergy and Infectious Diseases (NIAID)3
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)3
Northwestern University3
University of California, Los Angeles3
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic81
Scleroderma, Diffuse33
Autoimmune Diseases8
Raynaud Disease8
Connective Tissue Diseases7
Lupus Erythematosus, Systemic6
Dermatomyositis5
Lung Diseases, Interstitial5
Hypertension, Pulmonary4
Arthritis, Rheumatoid3

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.